Design, synthesis, and biological evaluation of diaryl heterocyclic derivatives targeting tubulin polymerization with potent anticancer activities. 2023

Gang Li, and Jia-Qiang Wu, and Xiaojia Cai, and Wen Guan, and Zhijun Zeng, and Yanghui Ou, and Xiaoyun Wu, and Jiayu Li, and Xiangxiang Fang, and Jinling Liu, and Yali Zhang, and Huamin Wang, and Canqiang Yin, and Hongliang Yao
Guangdong Key Laboratory of Animal Conservation and Resource Utilization, Guangdong Public Laboratory of Wild Animal Conservation and Utilization, Institute of Zoology, Guangdong Academy of Sciences, Guangzhou, Guangdong, 510260, China.

A series of diaryl heterocyclic analogues were designed and synthesized as tubulin polymerization inhibitors. Among them, compound 6y showed the highest antiproliferative activity against HCT-116 colon cancer cell line with an IC50 values of 2.65 μM. Compound 6y also effectively inhibited tubulin polymerization in vitro (IC50 of 10.9 μM), and induced HCT-116 cell cycle arrest in G2/M phase. In addition, compound 6y exhibited high metabolic stability on human liver microsomes (T1/2 = 106.2 min). Finally, 6y was also effective in suppressing tumor growth in a HCT-116 mouse colon model without apparent toxicity. Collectively, these results suggest that 6y represents a new class of tubulin inhibitors deserving further investigation.

UI MeSH Term Description Entries
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014404 Tubulin A microtubule subunit protein found in large quantities in mammalian brain. It has also been isolated from SPERM FLAGELLUM; CILIA; and other sources. Structurally, the protein is a dimer with a molecular weight of approximately 120,000 and a sedimentation coefficient of 5.8S. It binds to COLCHICINE; VINCRISTINE; and VINBLASTINE. alpha-Tubulin,beta-Tubulin,delta-Tubulin,epsilon-Tubulin,gamma-Tubulin,alpha Tubulin,beta Tubulin,delta Tubulin,epsilon Tubulin,gamma Tubulin
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D050257 Tubulin Modulators Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. Microtubule Modulator,Tubulin Inhibitor,Tubulin Modulator,Tubulin Polymerization Inhibitor,Tubulin Polymerization Promoter,Tubulin Promoter,Microtubule Modulators,Tubulin Inhibitors,Tubulin Polymerization Inhibitors,Tubulin Polymerization Promoters,Tubulin Promoters,Inhibitor, Tubulin,Inhibitor, Tubulin Polymerization,Inhibitors, Tubulin,Inhibitors, Tubulin Polymerization,Modulator, Microtubule,Modulator, Tubulin,Modulators, Microtubule,Modulators, Tubulin,Polymerization Inhibitor, Tubulin,Polymerization Inhibitors, Tubulin,Polymerization Promoter, Tubulin,Polymerization Promoters, Tubulin,Promoter, Tubulin,Promoter, Tubulin Polymerization,Promoters, Tubulin,Promoters, Tubulin Polymerization

Related Publications

Gang Li, and Jia-Qiang Wu, and Xiaojia Cai, and Wen Guan, and Zhijun Zeng, and Yanghui Ou, and Xiaoyun Wu, and Jiayu Li, and Xiangxiang Fang, and Jinling Liu, and Yali Zhang, and Huamin Wang, and Canqiang Yin, and Hongliang Yao
May 2021, Chemical biology & drug design,
Gang Li, and Jia-Qiang Wu, and Xiaojia Cai, and Wen Guan, and Zhijun Zeng, and Yanghui Ou, and Xiaoyun Wu, and Jiayu Li, and Xiangxiang Fang, and Jinling Liu, and Yali Zhang, and Huamin Wang, and Canqiang Yin, and Hongliang Yao
September 2021, Bioorganic & medicinal chemistry,
Gang Li, and Jia-Qiang Wu, and Xiaojia Cai, and Wen Guan, and Zhijun Zeng, and Yanghui Ou, and Xiaoyun Wu, and Jiayu Li, and Xiangxiang Fang, and Jinling Liu, and Yali Zhang, and Huamin Wang, and Canqiang Yin, and Hongliang Yao
December 2022, Bioorganic & medicinal chemistry,
Gang Li, and Jia-Qiang Wu, and Xiaojia Cai, and Wen Guan, and Zhijun Zeng, and Yanghui Ou, and Xiaoyun Wu, and Jiayu Li, and Xiangxiang Fang, and Jinling Liu, and Yali Zhang, and Huamin Wang, and Canqiang Yin, and Hongliang Yao
February 2024, European journal of medicinal chemistry,
Gang Li, and Jia-Qiang Wu, and Xiaojia Cai, and Wen Guan, and Zhijun Zeng, and Yanghui Ou, and Xiaoyun Wu, and Jiayu Li, and Xiangxiang Fang, and Jinling Liu, and Yali Zhang, and Huamin Wang, and Canqiang Yin, and Hongliang Yao
December 2024, Pharmaceutical biology,
Gang Li, and Jia-Qiang Wu, and Xiaojia Cai, and Wen Guan, and Zhijun Zeng, and Yanghui Ou, and Xiaoyun Wu, and Jiayu Li, and Xiangxiang Fang, and Jinling Liu, and Yali Zhang, and Huamin Wang, and Canqiang Yin, and Hongliang Yao
April 2019, European journal of medicinal chemistry,
Gang Li, and Jia-Qiang Wu, and Xiaojia Cai, and Wen Guan, and Zhijun Zeng, and Yanghui Ou, and Xiaoyun Wu, and Jiayu Li, and Xiangxiang Fang, and Jinling Liu, and Yali Zhang, and Huamin Wang, and Canqiang Yin, and Hongliang Yao
September 2020, European journal of medicinal chemistry,
Gang Li, and Jia-Qiang Wu, and Xiaojia Cai, and Wen Guan, and Zhijun Zeng, and Yanghui Ou, and Xiaoyun Wu, and Jiayu Li, and Xiangxiang Fang, and Jinling Liu, and Yali Zhang, and Huamin Wang, and Canqiang Yin, and Hongliang Yao
February 2022, European journal of medicinal chemistry,
Gang Li, and Jia-Qiang Wu, and Xiaojia Cai, and Wen Guan, and Zhijun Zeng, and Yanghui Ou, and Xiaoyun Wu, and Jiayu Li, and Xiangxiang Fang, and Jinling Liu, and Yali Zhang, and Huamin Wang, and Canqiang Yin, and Hongliang Yao
November 2018, Cells,
Gang Li, and Jia-Qiang Wu, and Xiaojia Cai, and Wen Guan, and Zhijun Zeng, and Yanghui Ou, and Xiaoyun Wu, and Jiayu Li, and Xiangxiang Fang, and Jinling Liu, and Yali Zhang, and Huamin Wang, and Canqiang Yin, and Hongliang Yao
January 2020, Bioorganic chemistry,
Copied contents to your clipboard!